Achillion Pharmaceuticals Inc (ACHN.OQ)


ACHN.OQ on NASDAQ Stock Exchange Global Select Market

8.01USD
4:00pm EDT
Price Change (% chg)

$0.08 (+1.01%)
Prev Close
$7.93
Open
$7.96
Day's High
$8.11
Day's Low
$7.93
Volume
267,364
Avg. Vol
261,822
52-wk High
$11.36
52-wk Low
$5.43

ACHN.OQ

Chart for ACHN.OQ

About

Achillion Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of treatments for infectious diseases. The Company is engaged in the development of antivirals for the treatment of chronic hepatitis C infection (HCV), and the development of antibacterials for the... (more)

Overall

Beta: 0.62
Market Cap (Mil.): $765.69
Shares Outstanding (Mil.): 96.56
Dividend: --
Yield (%): --

Financials

  ACHN.OQ Industry Sector
P/E (TTM): -- 39.38 31.28
EPS (TTM): -0.64 -- --
ROI: -38.28 2.42 18.90
ROE: -38.40 3.64 19.80
Search Stocks

Competitors

  Price Change
Pfizer Inc. (PFE.N) $29.40 +0.24
Johnson & Johnson (JNJ.N) $86.36 +0.73
Novartis AG (NOVN.VX) CHF67.15 -0.60
Merck & Co., Inc. (MRK.N) $47.75 -0.05
Roche Holding Ltd. (ROG.VX) CHF228.90 -2.20
Abbott Laboratories (ABT.N) $37.51 +0.62
AstraZeneca plc (AZN.L) 3,250.50p +4.00
GlaxoSmithKline plc (GSK.L) 1,676.00p -10.00
Bristol Myers Squibb Co. (BMY.N) $46.85 +0.41
Bristol Myers Squibb Co. (BMYMP.PK) -- --

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Achillion Pharmaceuticals, Inc.
Provider: Datamonitor
$175.00
Buy
Thomson Reuters Stock Report - ACHILLION PHARMACEUTICALS, INC. (ACHN-O)
Provider: Thomson Reuters Stock Report
$25.00
Buy
Market Edge Equity Research Report
Provider: Market Edge
$10.00
Buy
Achillion Pharmaceuticals
Provider: S&P Capital IQ Quantitative Report
$69.00
Buy
ACHILLION PHARMACEUTICALS INC (ACHN) 12-months forecast
Provider: Pechala's Reports
$15.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research
Search Stocks